eMedicine Specialties > Sports Medicine > Foot and Ankle
Plantar Fasciitis: Treatment & Medication
Updated: Jan 18, 2008
- Overview
- Differential Diagnoses & Workup
- Treatment & Medication
- Follow-up
- Multimedia
Treatment
Acute Phase
Rehabilitation Program
Physical Therapy
The initial physical therapy program for plantar fasciitis emphasizes stretching of the calf and foot. The stretching program should include wall stretches, with the knee in both the extended and flexed positions.
- To perform a wall stretch, the athlete should stand 3 feet from a wall, placing the hands on the wall. Keeping the toes pointed straight and the heel on the ground, the athlete leans the hips toward the wall, then holds this position for 30-40 seconds (see Image 2).5 Stretches targeted at the plantar fascia are particularly important.8
- In one study, iontophoresis was found to increase the speed of resolution of plantar fasciitis, although it had no effect on long-term outcome.9
Medical Issues/Complications
- Ice is the first-line anti-inflammatory treatment for plantar fasciitis. Icing should be performed after completing exercise, stretching, and strengthening, and this treatment can be applied by ice massage, ice bath, or ice pack.
- For ice massage, the athlete freezes water in a small paper or polystyrene cup and then rubs the ice over the painful heel, using a circular motion and moderate pressure for 5-10 minutes.
- For an ice bath, a shallow pad is filled with water and ice. The athlete soaks the heel for 10-15 minutes. Note: To prevent cold injuries, the athlete should use neoprene toe covers, or keep the toes out of the ice water.
- An ice pack can be made by placing crushed ice in a plastic bag that is wrapped in a towel. The use of crushed ice allows the ice pack to be molded to the foot and increases the contact area; a good alternative is a bag of prepackaged frozen corn kernels wrapped in a towel. Ice packs are usually placed for 15-20 minutes.
Other Treatment
Resting and correcting training errors are critical to the treatment of plantar fasciitis. Athletes must modify activities that aggravate this condition; such modifications may be as simple as decreasing the amount, frequency, or intensity of the inciting activity(ies). Athletes are more compliant with a decreased level of activity if they are allowed to increase other nonaggravating activities.10
- Replacing worn-out shoes and selecting appropriate shoes are also important. Runners should replace shoes every 250-500 miles (400-800 km) to maintain optimum shoe cushioning.7
- Runners who overpronate and who have pes planus should select motion-control shoes, which typically feature a straight-lasted, board-lasted, or combination-lasted construction; an external heel counter; a wider flare; and extra medial support.7
- Runners who have pes cavus should select shoes that have greater cushioning properties.
- All distance runners should practice in training flats that are better cushioned, reserving the lighter weight, less-cushioned racing flats for competition.
- Extracorporeal shock wave therapy (ESWT) has been proposed as a treatment option for plantar fasciitis. There appears to be few, if any, adverse side effects from this treatment modality. However, to date, results from studies are mixed.11,12,13,14,15,16,17
Recovery Phase
Rehabilitation Program
Physical Therapy
A strengthening program that emphasizes intrinsic foot muscle strengthening is added in the next phase of physical therapy. Exercises include towel curls, marble pick-ups, and toe taps.5
- For a towel curl, the athlete sits with the affected foot lying flat on the end of a towel that is placed on a smooth surface. The athlete pulls the towel toward the body by using the toes to curl up the towel while keeping the heel on the floor. As the athlete improves, add weight to the far end of the towel to increase the difficulty of this exercise (see Image 3).
- To do marble pick-ups, the athlete places a few marbles on the floor near a cup, picks them up with the toes, and drops them in the cup while keeping the heel on the floor. For a greater challenge, the athlete may try to pick up coins instead of marbles.
- To do toe taps, the athlete lifts all the toes off the floor; while keeping the heel on the floor and the outside 4 toes in the air, repetitively taps just the big toe to the floor (see Image 4). Next, the athlete reverses the process and repetitively taps the outside 4 toes to the floor while keeping the big toe in the air.
Medical Issues/Complications
Anti-inflammatory medications are frequently used to treat plantar fasciitis. Although there is controversy as to whether or not nonsteroidal anti-inflammatory drugs (NSAIDs) actually assist in the physiologic healing process, these agents can be useful as an adjunct to control pain while the individual's plantar fasciitis is being treated with stretching, strengthening, and relative rest (see the Medication section, below).18,19
Surgical Intervention
For cases that do not respond to conservative treatment, a surgical release of the plantar fascia may be considered. Overall, surgical release has a 70-90% success rate in treating patients with this condition; open, endoscopic, or radiofrequency lesioning techniques may be used.20,21,22,23,24,25,26
Potential complications of surgical intervention include flattening of the longitudinal arch and heel hypoesthesia, as well as those that are associated with plantar fascia rupture and corticosteroid injections. Longitudinal arch strain appears to account for over 50% of the chronic complications.27,28
Other Treatment (Injection, manipulation, etc.)
Corticosteroid injections
- In cases of recalcitrant plantar fasciitis, corticosteroid injection may be considered. Other causes of heel pain should also be considered, and a plain radiograph of the foot or calcaneus should always be obtained before injecting steroids.
- A corticosteroid injection may be given through a plantar or a medial approach, with or without ultrasound guidance. Studies have reported success rates of 70% or better.29,30 Potential risks include plantar fascia rupture, which was found in almost 10% of patients after plantar fascia injection in one case series27 and fat pad atrophy.27,28 Long-term sequelae were found in approximately 50% the patients with plantar fascia rupture.27
- The use of autologous blood injected into the plantar fascia origin is thought to stimulate an acute inflammatory reaction that leads to reinitiation of the healing process. This treatment has been shown to be effective in limited studies of chronic inflammatory musculotendinous conditions.31,32,33
Night splints
- Most people naturally sleep with their feet in a plantar-flexed position, which causes the plantar fascia to be shortened. Night splints are designed to keep the ankle in a neutral position during sleep, essentially passively stretching the calf and the plantar fascia for a prolonged period.
- Theoretically, the night splint allows the plantar fascia to heal in the elongated position, which, in turn, decreases the tension on the fascia with the first step in the morning. A night splint can be molded from either plaster or fiberglass casting material, or a prefabricated and commercially produced plastic brace can be used (see Image 5).
- Studies have shown that approximately 80% of patients using night splints had improvement of their plantar fasciitis.34,35,36,37,38 The splints are especially useful in individuals who have had symptoms of plantar fasciitis for longer than 12 months.34,35,36,37
Maintenance Phase
Rehabilitation Program
Physical Therapy
To minimize the chances of reoccurrence of plantar fasciitis, athletes should continue on a maintenance program of daily stretching and/or strengthening at least 2-3 times per week.
Other Treatment
Other treatment may include orthotic devices and arch supports.
- Patients with low arches place increased stress on the plantar fascia with foot strike and have a decreased ability to absorb the forces that are generated by foot strike.7 Mechanical corrections for pes planus include taping of the arches, over-the-counter (OTC) arch supports, and custom orthotic devices. Studies have found significant benefit to these conservative treatments when used in appropriate patients.19,39
- Arch taping can be used as a definitive treatment or as a trial to determine whether the expense of arch supports or orthotics is worthwhile for a patient. Taping may be more cost-effective for the acute onset of plantar fasciitis, whereas OTC arch supports and orthotics may be more cost-effective for chronic or recurrent cases of plantar fasciitis and for the prevention of injuries (the arches must be retaped for each practice or game).
- OTC arch supports usually last a full season; custom orthotic devices should last many seasons. OTC arch supports are especially useful in athletes with acute plantar fasciitis and mild pes planus, particularly adolescents whose rapid foot growth may require one or more new pairs of arch supports per season.
- Custom orthotic devices are designed to control biomechanical risk factors such as pes planus, valgus heel alignment, and leg-length discrepancies. Athletes treated with orthotic devices usually require semi-rigid, three-quarter to full-length orthotic devices with longitudinal arch support to control overpronation and metatarsal head motion, especially of the first metatarsal head.40 The main disadvantage in the use of orthotic devices is the cost, which ranges from $75 to $300 or more; frequently, these devices are not covered by insurance.
Medication
The goals of pharmacotherapy are to reduce morbidity and prevent complications.
Nonsteroidal anti-inflammatory drugs
The use of NSAIDs in chronic inflammatory diseases such as plantar fasciitis is somewhat controversial.18 NSAIDs may or may not be beneficial to the physiologic processes of soft-tissue healing. However, NSAIDs have been found to be useful in controlling pain (a useful adjunct in allowing more rapid progress with physical therapy) and in controlling acute inflammation. The disadvantages of these medications are many, including the risk of gastrointestinal (GI) bleeding, gastric pain, and renal damage.41
Ibuprofen (Motrin, Ibuprin, Advil)
Member of the propionic acid group of NSAIDs. Available in low-dose form as an OTC medication. Highly protein bound, metabolized in the liver, and eliminated primarily in the urine. Ibuprofen may reversibly inhibit platelet function.
Adult
600-800 mg PO tid/qid
Pediatric
Maximum 40 mg/kg PO divided tid/qid
Coadministration with aspirin increases the risk of inducing serious NSAID-related side effects; probenecid may increase the concentrations and, possibly, the toxicity of NSAIDs; may decrease the effect of hydralazine, captopril, and beta-blockers; may decrease the diuretic effects of furosemide and thiazides; may increase PT duration when taking anticoagulants (instruct patients to watch for signs of bleeding); may increase the risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently
Documented hypersensitivity; patients with peptic ulcer disease, recent GI bleeding or perforation, renal insufficiency, or high risk of bleeding
Pregnancy
B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
D - Fetal risk shown in humans; use only if benefits outweigh risk to fetus
Precautions
Caution in patients with congestive heart failure, hypertension, and decreased renal and hepatic function; caution in the presence of anticoagulation abnormalities or during anticoagulant therapy
Naproxen (Aleve, Anaprox, Naprosyn, Naprelan)
Member of the propionic acid group of NSAIDs. Available in low-dose form as an over-the-counter medication. Highly protein bound, metabolized in the liver, and eliminated primarily in the urine. Naproxen may reversibly inhibit platelet function.
Adult
250-550 mg PO bid/tid; maximum 1100 mg when used for pain control and acute musculoskeletal injury; maximum daily dose is 1650 mg for all conditions
Pediatric
Maximum 10 mg/kg PO divided bid
Coadministration with aspirin increases the risk of inducing serious NSAID-related side effects; probenecid may increase the concentrations and, possibly, the toxicity of NSAIDs; may decrease the effect of hydralazine, captopril, and beta-blockers; may decrease the diuretic effects of furosemide and thiazides; may increase PT duration when taking anticoagulants (instruct patients to watch for signs of bleeding); may increase the risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently
Documented hypersensitivity; peptic ulcer disease; recent GI bleeding or perforation; renal insufficiency
Pregnancy
B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
D - Fetal risk shown in humans; use only if benefits outweigh risk to fetus
Precautions
Acute renal insufficiency, interstitial nephritis, hyperkalemia, hyponatremia, and renal papillary necrosis may occur; patients with preexisting renal disease or compromised renal perfusion risk acute renal failure; leukopenia occurs rarely, is transient, and usually returns to normal during therapy; persistent leukopenia, granulocytopenia, or thrombocytopenia warrants further evaluation and may require discontinuation of the drug.
Corticosteroids
Corticosteroids are strong anti-inflammatory agents. The general risks involved with the use of these agents include skin atrophy, skin hypopigmentation, soft-tissue atrophy, infection, bleeding, and failure to work. A steroid flare-up, which consists of increased pain for up to several days, may occur in up to 2% of individuals who use corticosteroids.42
Triamcinolone acetonide (Amcort)
Injectable corticosteroid, used to treat localized areas of inflammation. Good evidence exists to suggest that injected corticosteroids alter the long-term pathology of chronic inflammation18,42 ; however, many patients receive acute symptomatic improvement.42 Triamcinolone acetonide is an injectable intermediate-acting, steroid anti-inflammatory agent.
Adult
1 mL of 40 mg/mL solution injected into plantar fascia origin via central or lateral approach
Pediatric
Administer as in adults
Local anesthetics containing the preservatives methylparaben, propylparaben, and phenol may cause flocculation of the steroid; corticosteroids may blunt antibody response in patients receiving immunizations concomitantly
Documented hypersensitivity; fungal, viral, and bacterial skin infections
Pregnancy
C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
Precautions
Injectable corticosteroids in pregnancy have not been studied; carefully monitor infants for hypoadrenalism when born to mothers who have received substantial exposure to corticosteroids; caution in patients with exposure to chicken pox, strongyloides infestation, active tuberculosis, ocular herpes simplex, psychiatric conditions, ulcerative colitis, diverticulitis, recent intestinal anastomoses, history of peptic ulcer disease, renal insufficiency, hypertension, osteoporosis, diabetes mellitus, thromboembolic disorders, seizures, hypoalbuminemia, hypothyroidism, cirrhosis, hyperlipidemias, glaucoma, cataracts and myasthenia gravis; caution in children, as growth and development may be affected by prolonged courses of corticosteroids, especially if given systemically
Betamethasone sodium (Celestone, Soluspan)
Injectable corticosteroid, used to treat localized areas of inflammation. No good evidence exists to suggest that injected corticosteroids alter the long-term pathology of chronic inflammation; however, many patients receive acute symptomatic improvement.42 Betamethasone sodium is an injectable intermediate-acting, steroid anti-inflammatory agent.
Adult
Inject 0.5 mL of 6 mg/mL solution into plantar fascia origin via central or lateral approach
Pediatric
Administer as in adults
Local anesthetics containing the preservatives methylparaben, propylparaben, and phenol may cause flocculation of the steroid; corticosteroids may blunt antibody response in patients concomitantly receiving immunizations
Documented hypersensitivity; patients with fungal, viral, and bacterial skin infections
Pregnancy
C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
Precautions
Injectable corticosteroids in pregnancy have not been studied; carefully monitor infants for hypoadrenalism when born to mothers who have received substantial exposure to corticosteroids; caution in patients with exposure to chicken pox, strongyloides infestation, active tuberculosis, ocular herpes simplex, psychiatric conditions, ulcerative colitis, diverticulitis, recent intestinal anastomoses, history of peptic ulcer disease, renal insufficiency, hypertension, osteoporosis, diabetes mellitus, thromboembolic disorders, seizures, hypoalbuminemia, hypothyroidism, cirrhosis, hyperlipidemias, glaucoma, cataracts, and myasthenia gravis; caution in children because growth and development may be affected by prolonged courses of corticosteroids, especially if given systemically
More on Plantar Fasciitis |
| Overview: Plantar Fasciitis |
| Differential Diagnoses & Workup: Plantar Fasciitis |
Treatment & Medication: Plantar Fasciitis |
| Follow-up: Plantar Fasciitis |
| Multimedia: Plantar Fasciitis |
| References |
| « Previous Page | Next Page » |
References
Singh D, Angel J, Bentley G, Trevino SG. Fortnightly review. Plantar fasciitis. BMJ. Jul 19 1997;315(7101):172-5. [Medline]. [Full Text].
Moseley JB Jr, Chimenti BT. Foot and ankle injuries in the professional athlete. In: Baxter DE, ed. The Foot and Ankle in Sport. St. Louis, Mo: Mosby-Year Book; 1995:321-8.
Riddle DL, Pulisic M, Pidcoe P, Johnson RE. Risk factors for Plantar fasciitis: a matched case-control study. J Bone Joint Surg Am. May 2003;85-A(5):872-7. [Medline].
Cavanagh PR, Lafortune MA. Ground reaction forces in distance running. J Biomech. 1980;13(5):397-406. [Medline].
Young CC, Rutherford DS, Niedfeldt MW. Treatment of plantar fasciitis. Am Fam Physician. Feb 1 2001;63(3):467-74, 477-8. [Medline]. [Full Text].
De Garceau D, Dean D, Requejo SM, Thordarson DB. The association between diagnosis of plantar fasciitis and Windlass test results. Foot Ankle Int. Mar 2003;24(3):251-5. [Medline].
Reid DC. Running: injury patterns and prevention. Sports Injury Assessment and Rehabilitation. New York, NY: Churchill Livingstone; 1992:1131-58.
DiGiovanni BF, Nawoczenski DA, Lintal ME, et al. Tissue-specific plantar fascia-stretching exercise enhances outcomes in patients with chronic heel pain. A prospective, randomized study. J Bone Joint Surg Am. Jul 2003;85-A(7):1270-7. [Medline].
Gudeman SD, Eisele SA, Heidt RS Jr, Colosimo AJ, Stroupe AL. Treatment of plantar fasciitis by iontophoresis of 0.4% dexamethasone. A randomized, double-blind, placebo-controlled study. Am J Sports Med. May-Jun 1997;25(3):312-6. [Medline].
Quillen WS, Magee DJ, Zachazewski JE. The process of athletic injury and rehabilitation. Athletic Injuries and Rehabilitation. Philadelphia, Pa: WB Saunders Co; 1996:3-8.
Ogden JA, Cross GL, Williams SS. Bilateral chronic proximal plantar fasciopathy: treatment with electrohydraulic orthotripsy. Foot Ankle Int. May 2004;25(5):298-302. [Medline].
Ogden JA, Alvarez RG, Levitt RL, Johnson JE, Marlow ME. Electrohydraulic high-energy shock-wave treatment for chronic plantar fasciitis. J Bone Joint Surg Am. Oct 2004;86-A(10):2216-28. [Medline].
Rompe JD, Decking J, Schoellner C, Nafe B. Shock wave application for chronic plantar fasciitis in running athletes. A prospective, randomized, placebo-controlled trial. Am J Sports Med. Mar-Apr 2003;31(2):268-75. [Medline].
Speed CA, Nichols D, Wies J, et al. Extracorporeal shock wave therapy for plantar fasciitis. A double blind randomised controlled trial. J Orthop Res. Sep 2003;21(5):937-40. [Medline].
Hammer DS, Adam F, Kreutz A, Kohn D, Seil R. Extracorporeal shock wave therapy (ESWT) in patients with chronic proximal plantar fasciitis: a 2-year follow-up. Foot Ankle Int. Nov 2003;24(11):823-8. [Medline].
Theodore GH, Buch M, Amendola A, et al. Extracorporeal shock wave therapy for the treatment of plantar fasciitis. Foot Ankle Int. May 2004;25(5):290-7. [Medline].
Mehra A, Zaman T, Jenkin AI. The use of a mobile lithotripter in the treatment of tennis elbow and plantar fasciitis. Surgeon. Oct 2003;1(5):290-2. [Medline].
Stanley KL, Weaver JE. Pharmacologic management of pain and inflammation in athletes. Clin Sports Med. Apr 1998;17(2):375-92. [Medline].
Wolgin M, Cook C, Graham C, Mauldin D. Conservative treatment of plantar heel pain: long-term follow-up. Foot Ankle Int. Mar 1994;15(3):97-102. [Medline].
Daly PJ, Kitaoka HB, Chao EY. Plantar fasciotomy for intractable plantar fasciitis: clinical results and biomechanical evaluation. Foot Ankle. May 1992;13(4):188-95. [Medline].
Leach RE, Seavey MS, Salter DK. Results of surgery in athletes with plantar fasciitis. Foot Ankle. Dec 1986;7(3):156-61. [Medline].
Benton-Weil W, Borrelli AH, Weil LS Jr, Weil LS Sr. Percutaneous plantar fasciotomy: a minimally invasive procedure for recalcitrant plantar fasciitis. J Foot Ankle Surg. Jul-Aug 1998;37(4):269-72. [Medline].
Sollitto RJ, Plotkin EL, Klein PG, Mullin P. Early clinical results of the use of radiofrequency lesioning in the treatment of plantar fasciitis. J Foot Ankle Surg. May-Jun 1997;36(3):215-9; discussion 256. [Medline].
Boyle RA, Slater GL. Endoscopic plantar fascia release: a case series. Foot Ankle Int. Feb 2003;24(2):176-9. [Medline].
Conflitti JM, Tarquinio TA. Operative outcome of partial plantar fasciectomy and neurolysis to the nerve of the abductor digiti minimi muscle for recalcitrant plantar fasciitis. Foot Ankle Int. Jul 2004;25(7):482-7. [Medline].
Jerosch J, Schunck J, Liebsch D, Filler T. Indication, surgical technique and results of endoscopic fascial release in plantar fasciitis (E FRPF). Knee Surg Sports Traumatol Arthrosc. Sep 2004;12(5):471-7. [Medline].
Acevedo JI, Beskin JL. Complications of plantar fascia rupture associated with corticosteroid injection. Foot Ankle Int. Feb 1998;19(2):91-7. [Medline].
Sellman JR. Plantar fascia rupture associated with corticosteroid injection. Foot Ankle Int. Jul 1994;15(7):376-81. [Medline].
Kane D, Greaney T, Bresnihan B, Gibney R, FitzGerald O. Ultrasound guided injection of recalcitrant plantar fasciitis. Ann Rheum Dis. Jun 1998;57(6):383-4. [Medline]. [Full Text].
Furey JG. Plantar fasciitis. The painful heel syndrome. J Bone Joint Surg Am. Jul 1975;57(5):672-3. [Medline].
Martin RP. Autologous blood injection for plantar fasciitis: a retrospective study. Paper presented at: Annual meeting of the American Medical Society for Sports Medicine; April 16-20, 2005; Austin, Texas. Clin J Sport Med. Sept 2005;15:387-8.
Kiter E, Celikbas E, Akkaya S, Demirkan F, Kiliç BA. Comparison of injection modalities in the treatment of plantar heel pain: a randomized controlled trial. J Am Podiatr Med Assoc. Jul-Aug 2006;96(4):293-6. [Medline].
Lee TG, Ahmad TS. Intralesional autologous blood injection compared to corticosteroid injection for treatment of chronic plantar fasciitis. A prospective, randomized, controlled trial. Foot Ankle Int. Sep 2007;28(9):984-90. [Medline].
Batt ME, Tanji JL, Skattum N. Plantar fasciitis: a prospective randomized clinical trial of the tension night splint. Clin J Sport Med. Jul 1996;6(3):158-62. [Medline].
Wapner KL, Sharkey PF. The use of night splints for treatment of recalcitrant plantar fasciitis. Foot Ankle. Dec 1991;12(3):135-7. [Medline].
Powell M, Post WR, Keener J, Wearden S. Effective treatment of chronic plantar fasciitis with dorsiflexion night splints: a crossover prospective randomized outcome study. Foot Ankle Int. Jan 1998;19(1):10-8. [Medline].
Mizel MS, Marymont JV, Trepman E. Treatment of plantar fasciitis with a night splint and shoe modification consisting of a steel shank and anterior rocker bottom. Foot Ankle Int. Dec 1996;17(12):732-5. [Medline].
Berlet GC, Anderson RB, Davis H, Kiebzak GM. A prospective trial of night splinting in the treatment of recalcitrant plantar fasciitis: the Ankle Dorsiflexion Dynasplint. Orthopedics. Nov 2002;25(11):1273-5. [Medline].
Lynch DM, Goforth WP, Martin JE, et al. Conservative treatment of plantar fasciitis. A prospective study. J Am Podiatr Med Assoc. Aug 1998;88(8):375-80. [Medline].
Kwong PK, Kay D, Voner RT, White MW. Plantar fasciitis. Mechanics and pathomechanics of treatment. Clin Sports Med. Jan 1988;7(1):119-26. [Medline].
McCarthy D. Nonsteroidal anti-inflammatory drug-related gastrointestinal toxicity: definitions and epidemiology. Am J Med. Nov 2 1998;105(5A):3S-9S. [Medline].
Pfenninger JL. Joint and soft tissue aspiration and injection. In: Pfenninger JL, Fowler GC, eds. Procedures for Primary Care Physicians. St. Louis, Mo: Mosby-Year Book; 1994:1036-54.
Martin RL, Irrgang JJ, Conti SF. Outcome study of subjects with insertional plantar fasciitis. Foot Ankle Int. Dec 1998;19(12):803-11. [Medline].
Further Reading
Keywords
heel spurs, heel pain, inflammation of the plantar fascia, calcaneal pain
Treatment & Medication: Plantar Fasciitis